← The Wire
QTTBNasdaq
Q32 Bio Inc.
Pharmaceutical Preparations · DE · CIK 1661998
Develops novel biologics to restore immune balance for autoimmune and inflammatory diseases
$214M
Market cap
$14.14
Last close
+7.4%
1D
+11.8%
5D
722K
Volume
Price · last 39 sessions+180.6%
May 4L $5.04 · H $14.14Jun 29
150
Total filings
Jun 16, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 16, 2026SC 13D/ASC 13D/AJun 1, 2026SC 13D/ASC 13D/AMay 28, 20268-KMaterial Agreement · Equity IssuanceMay 27, 2026SC 13D/ASC 13D/AMay 6, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 30, 2026DEF 14ADEF 14AApr 30, 20268-KCompany UpdateApr 24, 2026424B5424B5Apr 24, 20268-KMaterial AgreementMar 27, 2026424B5424B5Mar 27, 2026SC 13D/ASC 13D/AMar 12, 202610-K10-KMar 10, 20268-KResults of OperationsMar 10, 20268-KMaterial Agreement · Company UpdateFeb 17, 2026424B5424B5Feb 17, 20268-KExecutive ChangeDec 19, 20258-KMaterial Agreement · Agreement TerminatedDec 1, 202510-Q10-QNov 13, 20258-KResults of OperationsNov 13, 20258-KCompany UpdateOct 21, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KExecutive Change · Reg FD DisclosureJun 25, 20258-KSecurity-Holder Rights · Bylaw AmendmentJun 17, 20258-KDelisting NoticeMay 23, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KExecutive ChangeApr 25, 202510-K10-KMar 11, 20258-KResults of OperationsMar 11, 20258-KCompany UpdateMar 10, 20258-KExit / Disposal Costs · Reg FD DisclosureFeb 10, 20258-KReg FD DisclosureJan 13, 20258-KReg FD Disclosure · Company UpdateDec 11, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KReg FD Disclosure · Company UpdateJul 9, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024S-1FORM S-1Apr 19, 202410-K/A10-K/AApr 12, 2024SC 13DQ32 BIO INC.Apr 4, 2024SC 13DSC 13DApr 1, 2024SC 13DSCHEDULE 13DMar 28, 20248-KAuditor Change · Change of ControlMar 27, 20248-K/ACompany UpdateMar 22, 20248-KCompany UpdateMar 20, 20248-KShareholder VoteMar 15, 202410-K10-KMar 13, 2024425425Mar 11, 20248-KCompany UpdateMar 11, 2024425425Feb 21, 2024425425Jan 26, 20248-KReg FD DisclosureJan 26, 2024425425Jan 3, 20248-KDelisting Notice · Reg FD DisclosureJan 3, 2024S-4S-4Dec 18, 2023425425Nov 16, 2023425425Nov 16, 2023425425Nov 16, 2023425425Nov 16, 20238-KChange of Control · Executive ChangeNov 16, 2023425425Nov 16, 20238-KReg FD DisclosureNov 16, 202310-Q10-QNov 14, 20238-KReg FD DisclosureOct 10, 202310-Q10-QAug 14, 20238-KExit / Disposal Costs · Company UpdateJul 27, 20238-KShareholder VoteJun 14, 202310-Q10-QMay 11, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 202310-K10-KMar 9, 2023
Insider Activity
In the 90 days to Feb 25, 2026: 3 sold $185K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 25, 2026 | Morrison Jodie PopeCEO | Sell | 9,896 | $4.51 | $45K |
| Feb 25, 2026 | Kalowski LeeCFO and President | Sell | 3,995 | $4.51 | $18K |
| Feb 25, 2026 | Violette Shelia M.Chief Scientific Officer | Sell | 2,815 | $4.51 | $13K |
| Dec 2, 2025 | Morrison Jodie PopeCEO | Sell | 22,506 | $3.46 | $78K |
| Dec 2, 2025 | Kalowski LeeCFO and President | Sell | 9,072 | $3.46 | $31K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance